AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2022
Nov 3, 2022
62608_rns_2022-11-03_cc3d2c58-9ee1-4716-8d75-8d2d8d99717b.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
November 03, 2022
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
November 14, 2022 at 9:30 a.m. – 10:30 a.m. (IST) , for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Ltd.
HARISH Digitally signed by HARISH VINAYA VINAYAK KUBER Date: 2022.11.03 K KUBER 18:28:11 +05'30'
Harish Kuber
Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Encl: As above
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099, India T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]
==> picture [139 x 99] intentionally omitted <==
I N V I T A T I O N
Glenmark Q2 FY 2022 – 23 Results Earnings Call
Date: Monday, November 14, 2022 Time: 9:30 am – 10:30 am [IST]
Dial – in Numbers: Universal Access Number: +91 22 6280 1298 +91 22 7115 8199 USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448
To pre-register online, please click here
For any clarification, please contact:
Aarti Ramakrishnan
E-mail: [email protected]
Phone: +91 22 4018 9147